Cargando…
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma http://bit.ly/2D2yYSK
Autores principales: | Kent, Brian D., d'Ancona, Grainne, Fernandes, Mariana, Green, Linda, Roxas, Cris, Thomson, Louise, Nanzer, Alexandra M., Kavanagh, Joanne, Agarwal, Sangita, Jackson, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970182/ https://www.ncbi.nlm.nih.gov/pubmed/31984211 http://dx.doi.org/10.1183/23120541.00311-2019 |
Ejemplares similares
-
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020) -
Eosinophilic granulomatosis with polyangiitis: case report and literature review
por: Alam, Vardah, et al.
Publicado: (2022) -
Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
por: Mattsson, Gustav, et al.
Publicado: (2017) -
Eosinophilic Granulomatosis with Polyangiitis
por: Shukla, Ratnakar, et al.
Publicado: (2022) -
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)